General Regulation

Government set to ‘introduce’ hub-and-spoke legislation in 2025

 • comment0

The pharmacy minister has revealed government plans to implement hub-and-spoke legislation this year.

NHSE proposes offering Mounjaro to nearly 250,000 people over three years

 • comment0

NICE has opened a consultation on the possible mass rollout of tirzepatide to millions of people in England over the next decade.

PDA chair calls on pharmacists to support doctors in scope-creep battle

 • comment0

PDA chair Mark Koziol has encouraged pharmacists to contribute to a doctor group’s legal war chest as they challenge their regulator on scope creep from MAPs.

Promised hub-and-spoke legislation delayed indefinitely

 • comment0

The new government is “not in a position” to implement promised intercompany hub-and-spoke changes in January, the pharmacy negotiator has announced.

GPhC fails FtP timeliness evaluation again as performance ‘deteriorates’

 • comment0

The time taken by the General Pharmaceutical Council (GPhC) to resolve FtP cases “deteriorated” in 2023/24, the Professional Standards Authority (PSA) has found in its performance review of the regulator.

Seven pharmacists removed from register for ‘non-payment of fees’

 • comment0

Some seven pharmacists have been removed from the Northern Irish pharmacy register at once, it has revealed. 

PSNI fails to hire new chief executive amid concerns

 • comment0

Northern Ireland’s pharmacy regulator has been “unable” to hire a new chief executive, it has revealed.

Make superintendents ‘responsible’ for stricter Wegovy safeguards, says GPhC

 • comment0

“Not following” the pharmacy regulator’s proposed new guidance on weight loss drugs and online pharmacy prescribing could result in fitness-to-practise (FtP) investigations into “all the pharmacy professionals involved”, it has warned.  

Pharmacist empties Tesco of Ozempic for own private weight loss patients

 • comment0

Amardip Virdi bought the “entire stock” of Ozempic at a pharmacy where he was working during a national shortage to supply it to private weight loss customers, the GPhC’s investigating committee has found.

Appeal court reinstates mammoth hydrocortisone cartel fines

 • comment0

The Court of Appeal has reinstated mammoth fines imposed against manufacturers that had been set aside on procedural grounds earlier this year.